Click here to subscribe to PAAD!
Myron Yaster MD, Lynne G. Maxwell MD, and Rita Agarwal MD
Honorio T Benzon, Eric C Sun, Roger Chou. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose. Anesth Analg. 2022 Jul 1;135(1):21-25. PMID: 35709441 1
Scott D Nelson, Allison B McCoy, Hayley Rector, Andrew J Teare, Tyler W Barrett, Elizabeth A Sigworth, Qingxia Chen, David A Edwards, David E Marcovitz, Adam Wright. Assessment of a Naloxone Coprescribing Alert for Patients at Risk of Opioid Overdose: A Quality Improvement Project. Anesth Analg. 2022 Jul 1;135(1):26-34. PMID: 35343932 2
Should we be providing intranasal nasal coprescriptions to our patients and families at high risk of opioid overdose?
“I don’t need no stinkin’ quantitative neuromuscular blockade monitor”…you probably do
Myron Yaster MD, Lynne Maxwell MD, and Debra Faulk MD
Fülesdi B, Brull SJ. Quantitative Neuromuscular Monitoring: “Love All, Trust a Few, Do Wrong to None”. Anesth Analg. 2022 Jul 1;135(1):35-38. PMID: 35709442 1
Blobner M, Hollmann MW, Luedi MM, Johnson KB. Pro-Con Debate: Do We Need Quantitative Neuromuscular Monitoring in the Era of Sugammadex? Anesth Analg. 2022 Jul 1;135(1):39-48. PMID: 35709443 2
The pros and cons of quantitative neuromuscular blockade monitors are presented.
Another week and more mass shootings…I received several emails from readers asking for more information about the University of Washington (UW) Harborview Injury Prevention and Research Center from Monica S. Vavilala, MD. I asked Dr. Wendy Binstock and her (“civilian”) husband Eddie Rush who were at the 4th of July parade massacre in Chicago and provided first aid to the victims to recount some of their experiences. Finally, Justin Lockman sent some of his thoughts on intranasal naloxone.